Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

42.17
+1.754.33%
Post-market: 42.170.00000.00%19:30 EDT
Volume:151.58K
Turnover:6.33M
Market Cap:318.38M
PE:- -
High:42.27
Open:40.52
Low:40.52
Close:40.42
52wk High:43.44
52wk Low:23.90
Shares:7.55M
Float Shares:7.55M
Volume Ratio:0.88
T/O Rate:2.01%
Dividend:0.28
Dividend Rate:0.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data

Simply Wall St.
·
4 hours ago

Revolution Medicines (RVMD) Starts Phase 3 RASolute 309, Is It Still A Bargain?

Simply Wall St.
·
5 hours ago

Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target

Reuters
·
9 hours ago

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones
·
15 hours ago

US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains

MT Newswires Live
·
15 hours ago

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
16 hours ago

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why

TIPRANKS
·
17 hours ago

Moderna up over 11%, on Track for Highest Close Since January 2022

Dow Jones
·
18 hours ago

Vertex Pharmaceuticals to present data on Alyftrek at NACFC

TIPRANKS
·
18 hours ago

Sector Update: Healthcare

MT Newswires Live
·
18 hours ago

Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function

Reuters
·
18 hours ago

Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors

TIPRANKS
·
19 hours ago

Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.

Dow Jones
·
19 hours ago

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

TIPRANKS
·
19 hours ago

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
19 hours ago

Top Midday Gainers

MT Newswires Live
·
19 hours ago

Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200

TradingKey
·
Yesterday

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09

Reuters
·
Yesterday

Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT Newswires Live
·
Yesterday

NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump

MT Newswires Live
·
Yesterday